Literature DB >> 10364219

Effector recognition by the small GTP-binding proteins Ras and Ral.

B Bauer1, G Mirey, I R Vetter, J A García-Ranea, A Valencia, A Wittinghofer, J H Camonis, R H Cool.   

Abstract

The Ral effector protein RLIP76 (also called RIP/RalBP1) binds to Ral.GTP via a region that shares no sequence homology with the Ras-binding domains of the Ser/Thr kinase c-Raf-1 and the Ral-specific guanine nucleotide exchange factors. Whereas the Ras-binding domains have a similar ubiquitin-like structure, the Ral-binding domain of RLIP was predicted to comprise a coiled-coil region. In order to obtain more information about the specificity and the structural mode of the interaction between Ral and RLIP, we have performed a sequence space and a mutational analysis. The sequence space analysis of a comprehensive nonredundant assembly of Ras-like proteins strongly indicated that positions 36 and 37 in the core of the effector region are tree-determinant positions for all subfamilies of Ras-like proteins and dictate the specificity of the interaction of these GTPases with their effector proteins. Indeed, we could convert the specific interaction with Ras effectors and RLIP by mutating these residues in Ras and Ral. We therefore conclude that positions 36 and 37 are critical for the discrimination between Ras and Ral effectors and that, despite the absence of sequence homology between the Ral-binding and the Ras-binding domains, their mode of interaction is most probably similar.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10364219     DOI: 10.1074/jbc.274.25.17763

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  The Ras mutant D119N is both dominant negative and activated.

Authors:  R H Cool; G Schmidt; C U Lenzen; H Prinz; D Vogt; A Wittinghofer
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  Ral GTPases contribute to regulation of cyclin D1 through activation of NF-kappaB.

Authors:  D O Henry; S A Moskalenko; K J Kaur; M Fu; R G Pestell; J H Camonis; M A White
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

3.  Are protein-protein interfaces more conserved in sequence than the rest of the protein surface?

Authors:  Daniel R Caffrey; Shyamal Somaroo; Jason D Hughes; Julian Mintseris; Enoch S Huang
Journal:  Protein Sci       Date:  2004-01       Impact factor: 6.725

4.  Automated prediction of protein function and detection of functional sites from structure.

Authors:  Florencio Pazos; Michael J E Sternberg
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-29       Impact factor: 11.205

5.  RalA and RalB proteins are ubiquitinated GTPases, and ubiquitinated RalA increases lipid raft exposure at the plasma membrane.

Authors:  Vincent Neyraud; Vasily N Aushev; Anastassia Hatzoglou; Brigitte Meunier; Ilaria Cascone; Jacques Camonis
Journal:  J Biol Chem       Date:  2012-06-14       Impact factor: 5.157

6.  Ral inhibits ligand-independent Notch signaling in Drosophila.

Authors:  Bomsoo Cho; Janice A Fischer
Journal:  Small GTPases       Date:  2012-07-01

7.  Distinct roles of RalA and RalB in the progression of cytokinesis are supported by distinct RalGEFs.

Authors:  Ilaria Cascone; Rasim Selimoglu; Cafer Ozdemir; Elaine Del Nery; Charles Yeaman; Michael White; Jacques Camonis
Journal:  EMBO J       Date:  2008-08-28       Impact factor: 11.598

8.  Protein interactions and ligand binding: from protein subfamilies to functional specificity.

Authors:  Antonio Rausell; David Juan; Florencio Pazos; Alfonso Valencia
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-19       Impact factor: 11.205

9.  Structural basis of the interaction between RalA and Sec5, a subunit of the sec6/8 complex.

Authors:  Shuya Fukai; Hugo T Matern; Junutula R Jagath; Richard H Scheller; Axel T Brunger
Journal:  EMBO J       Date:  2003-07-01       Impact factor: 11.598

Review 10.  RLIP76: A novel glutathione-conjugate and multi-drug transporter.

Authors:  Sharad S Singhal; Sushma Yadav; Cherice Roth; Jyotsana Singhal
Journal:  Biochem Pharmacol       Date:  2008-10-15       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.